Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

In Reply: Reassessing Cancer Attribution and Methodological Limitations in PLA2R-Associated Membranous Nephropathy

Ilario Russo, Maria J Vargas-Brochero, Anila Cara

    Mayo Clinic Proceedings
    |June 15, 2026
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
    12:22

    The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

    Published on: January 22, 2013

    Related Experiment Videos

    Last Updated: Jun 17, 2026

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
    07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
    12:22

    The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers

    Published on: January 22, 2013

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Contactin-1 Membranous Nephropathy Without Neuropathy and Serum Antibodies.

    Kidney international reports·2026
    Same author

    Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

    The New England journal of medicine·2026
    Same author

    Response to the Letter to the Editor Entitled "Integrating Tissue Proteomics and Urinary Analysis to Capture Dynamic Podocyte Injury".

    Kidney international reports·2026
    Same author

    How to Manage an Adult Patient With IgA Nephropathy in the Current Era?

    Mayo Clinic proceedings·2026
    Same author

    A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy.

    Clinical kidney journal·2026
    Same author

    Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

    Kidney international reports·2026
    Same journal

    Thyroid Dysfunction and the Risk of Clinically Relevant Depression: A Longitudinal Cohort Study.

    Mayo Clinic proceedings·2026
    Same journal

    37-Year-Old Woman With Jaundice.

    Mayo Clinic proceedings·2026
    Same journal

    34-Year-Old Woman With An Unidentified Overdose.

    Mayo Clinic proceedings·2026
    Same journal

    Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

    Mayo Clinic proceedings·2026
    Same journal

    Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

    Mayo Clinic proceedings·2026
    Same journal

    RAAS Inhibition in the ICU: Stop, Continue, or Restart?

    Mayo Clinic proceedings·2026
    See all related articles